Showing 1 - 1 of 1
On 14 March 2007 the French Competition Council issued a decision imposing a EUR 10 million fine on GlaxoSmithKline France (GSK France) for predatory pricing. The investigation was the result of a complaint by a generic manufacturer, Flavelab, and resulted in the first ever predatory pricing...
Persistent link: https://www.econbiz.de/10008547557